Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms
Gastroenterology. 2021 Mar 3:S0016-5085(21)00461-3. doi: 10.1053/j.gastro.2021.02.056. Online ahead of print. PMID: 33676971
BACKGROUND AND AIMS: Given gastrointestinal (GI) symptoms are a prominent extrapulmonary manifestation of COVID–19, we investigated intestinal infection with SARS–CoV–2, its effect on pathogenesis, and clinical significance.